Back

Clinical outcomes and safety of SGLT2 inhibitor therapy in patients with a systemic right ventricle and heart failure: a pre-post analysis from the ACHIEVE-SGLT2i registry

28 August 2026 (15:55 - 16:05)
Organised by: Logo
Congress Presentation Part of: Adult congenital heart disease: phenotyping and outcomes Adult Congenital Heart Disease (ACHD) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Bjorn Nicolaas Westdorp

Leiden University Medical Center, Leiden (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Phenotyping for novel classification of adults with Fontan circulation by machine learning
Doctor M. Nakashima (Okayama, JP)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes in Tetralogy of Fallot: from the australian national congenital heart disease registry
Doctor J. Chami (Camperdown, AU)
Abstract Slides Video
Presentation thumbnail
A circular RNA based biomarker for transposition of the great arteries(TGA) hsa-PHACTR4_0009 upregulates cell migration during TGA pathogenesis.
Ms N. Neha (Chandigarh, IN)
Abstract Slides Video
Presentation thumbnail
Post-operative arrhythmias after tricuspid valve surgery in Ebstein's anomaly: incidence, predictors, and the role of pre-operative electrophysiology study
Doctor I. Gupta (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Prognostic value of composite hemodynamic indices in congenital heart disease-associated pulmonary hypertension: insights from a national multicenter prospective registry study
Miss Q. Yu (Nanchang, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Adult congenital heart disease: phenotyping and outcomes
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 15:55 CET
You may be interested in
thumbnail
Congress Presentation
Role of SGLT2I in improving right ventricular systolic function in patients with HFpEF
28 August 2026
thumbnail
Congress Presentation
Impact on adverse events of guideline-directed medical therapy for heart failure in patients with a systemic right ventricle
31 August 2025
thumbnail
Congress Presentation
Sodium-glucose cotransporter 2 inhibitors for the treatment of single ventricle circulatory failure in adults with congenital heart disease
31 August 2025
thumbnail
Congress Session
Novel metrics to improve outcomes in congenital heart disease
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources